Literature DB >> 20380965

Epidemiology of aneurysmal subarachnoid hemorrhage.

Brad E Zacharia1, Zachary L Hickman, Bartosz T Grobelny, Peter DeRosa, Ivan Kotchetkov, Andrew F Ducruet, E Sander Connolly.   

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a form of hemorrhagic stroke that affects up to 30,000 individuals per year in the United States. The incidence of aSAH has been shown to be associated with numerous nonmodifiable (age, gender, ethnicity, family history, aneurysm location, size) and modifiable (hypertension, body mass index, tobacco and illicit drug use) risk factors. Although early repair of ruptured aneurysms and aggressive postoperative management has improved overall outcomes, it remains a devastating disease, with mortality approaching 50% and less than 60% of survivors returning to functional independence. As treatment modalities change and the percentage of minority and elderly populations increase, it is critical to maintain an up-to-date understanding of the epidemiology of SAH. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20380965     DOI: 10.1016/j.nec.2009.10.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  58 in total

Review 1.  Neurovascular events after subarachnoid hemorrhage: focusing on subcellular organelles.

Authors:  Sheng Chen; Haijian Wu; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2015

Review 2.  [Neuroprotection in neurocritical care].

Authors:  Rainer Kollmar
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

3.  Blood transfusion is an important predictor of hospital mortality among patients with aneurysmal subarachnoid hemorrhage.

Authors:  Emir Festic; Alejandro A Rabinstein; William D Freeman; Elizabeth A Mauricio; Maisha T Robinson; Jay Mandrekar; Abba C Zubair; Augustine S Lee; Ognjen Gajic
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 4.  Intracranial hemorrhage.

Authors:  J Alfredo Caceres; Joshua N Goldstein
Journal:  Emerg Med Clin North Am       Date:  2012-08       Impact factor: 2.264

5.  Intraventricular fibrinolysis for severe aneurysmal intraventricular hemorrhage: a randomized controlled trial and meta-analysis.

Authors:  Stephane Litrico; Fabien Almairac; Thomas Gaberel; Rohan Ramakrishna; Denys Fontaine; Jacques Sedat; Michel Lonjon; Philippe Paquis
Journal:  Neurosurg Rev       Date:  2013-05-02       Impact factor: 3.042

6.  THSD1 (Thrombospondin Type 1 Domain Containing Protein 1) Mutation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage.

Authors:  Teresa Santiago-Sim; Xiaoqian Fang; Morgan L Hennessy; Stephen V Nalbach; Steven R DePalma; Ming Sum Lee; Steven C Greenway; Barbara McDonough; Georgene W Hergenroeder; Kyla J Patek; Sarah M Colosimo; Krista J Qualmann; John P Hagan; Dianna M Milewicz; Calum A MacRae; Susan M Dymecki; Christine E Seidman; J G Seidman; Dong H Kim
Journal:  Stroke       Date:  2016-11-15       Impact factor: 7.914

Review 7.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

8.  Deficiency of Tenascin-C Alleviates Neuronal Apoptosis and Neuroinflammation After Experimental Subarachnoid Hemorrhage in Mice.

Authors:  Lei Liu; Masashi Fujimoto; Fumi Nakano; Hirofumi Nishikawa; Takeshi Okada; Fumihiro Kawakita; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2018-03-15       Impact factor: 5.590

9.  Stem Cells as a Potential Adjunctive Therapy in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Hesham T Ghonim; Sumedh S Shah; John W Thompson; Sudheer Ambekar; Eric C Peterson; Mohamed Samy Elhammady
Journal:  J Vasc Interv Neurol       Date:  2016-01

10.  Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice.

Authors:  Lei Liu; Masashi Fujimoto; Fumihiro Kawakita; Fumi Nakano; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.